Connect with us

Technology

DR. DAVID AMRON TESTIFIES BEFORE U.S. SENATE SPECIAL COMMITTEE ON AGING ON AI-ENABLED FRAUD TARGETING OLDER AMERICANS

Published

2 months ago

on

Internationally Recognized Lipedema Surgeon Shares Firsthand Experience with AI-Generated Medical Impersonation and Calls for Stronger Protections for Patients

LOS ANGELES, Aug. 3, 2026 /PRNewswire/ — On Wednesday, July 29, 2026, Dr. David Amron, Founder and Medical Director of The Roxbury Institute and Founder and Chair of The Lipedema Society, appeared before the U.S. Senate Special Committee on Aging to testify during “The AI Deception Machine: Deepfakes, Chatbots, and the New Frontier of Senior Fraud.”

Dr. Amron joined Senate Special Committee on Aging Chairman Rick Scott, Ranking Member Kirsten Gillibrand, Senators Mark Kelly and Tommy Tuberville, other lawmakers, consumer advocates, cybersecurity experts, banking leaders, and a fraud victim to examine the growing threat artificial intelligence poses to older Americans.

Dr. Amron was invited to Washington to testify after his name, image, voice, and professional reputation were unlawfully used in a sophisticated AI-generated medical impersonation scam to promote a fraudulent so-called “miracle” lipedema cream. His appearance before the Committee focused on raising awareness, bringing the issue directly to Congress, and helping advance legislation to create stronger protections for patients, physicians, older Americans, and other consumers.

The deceptive advertisements incorporated authentic footage from Dr. Amron’s YouTube channel that was manipulated to make it appear he had endorsed the product. The scammers also created an entirely AI-generated likeness, image, and voice of his colleague, Dr. Karen Herbst, Head of Research and Director of Diagnostic and Preventative Medicine at The Roxbury Institute. AI-generated celebrity images and stolen media logos were also used to create polished advertisements that appeared entirely legitimate.

Several individuals purchased the fraudulent product before learning the advertisements were fabricated, including one of Dr. Amron’s own patients.

The scam first came to light after concerned patients began contacting The Roxbury Institute with questions about the advertisements. As soon as the fraud was identified, Dr. Amron and his team began investigating and reporting the coordinated scam to Facebook, the fraudulent social media accounts responsible for publishing the advertisements, the domain registrars hosting the websites, Google Ads, and the major search engines directing consumers to the scam.

Despite persistent reporting efforts, each time one version was removed, another quickly appeared, highlighting the limitations of existing reporting systems in combating coordinated AI-enabled fraud.

After exhausting every available reporting mechanism, Dr. Amron brought national attention to the issue through NBC’s TODAY Show, helping expose the sophisticated scam and educate consumers about the growing dangers of AI-generated medical impersonation.

The bipartisan Senate hearing examined how artificial intelligence is increasingly being exploited through deepfakes, voice cloning, chatbots, and other emerging technologies to target older Americans with sophisticated scams. Throughout the hearing, lawmakers and expert witnesses emphasized the urgent need for stronger consumer protections, greater accountability, improved public education, and enhanced collaboration between government and the private sector.

“What disturbed me most was not that someone had misused my image. It was knowing that scammers had used my name and reputation to deceive the very people I have dedicated my career to helping,” said Dr. David Amron. “This problem is no longer theoretical. It is happening right now, and the consequences for patient safety, medical ethics, and the integrity of healthcare information are profound.”

During his testimony, Dr. Amron warned that the consequences of AI-generated medical fraud extend far beyond financial loss. Patients may delay legitimate medical care for a progressive disease like lipedema, rely on products falsely presented as physician-endorsed, and allow their condition to worsen, and allow their condition to worsen.

Perhaps most damaging, these scams erode the trust patients place in their physicians, leaving them uncertain about whom they can trust for legitimate medical guidance.

Dr. Amron also urged Congress to improve accountability for those who create and distribute AI-generated impersonation scams and ensure that laws keep pace with rapidly advancing technology.

His testimony underscored the growing threat AI-enabled fraud poses not only to older Americans, but also to patient safety, medical ethics, and public trust in healthcare. By sharing his firsthand experience, Dr. Amron hopes to help drive meaningful policy solutions that better protect patients and consumers from increasingly sophisticated AI-generated deception.

For interviews or media inquiries, please contact:
Natalia Grazziani
Grazziani Communications
natalia@grazzianicommunications.com
323-646-1581

About The Roxbury Institute

The Roxbury Institute, founded by Dr. David Amron in Los Angeles, is a nationally recognized multidisciplinary center specializing in advanced treatment for individuals with fat disorders and those seeking aesthetic and medical dermatology care. Built on clinical excellence and innovative research, the Institute has offices in Salt Lake City and Tucson. Its specialties include advanced lipedema treatment, liposculpture, and revision liposuction, supported by divisions in Research, Diagnosis and Prevention, Advanced Lipedema Treatment, and Aesthetic Medicine and Dermatology. These programs address complex and often misunderstood conditions while advancing scientific knowledge, setting national standards of care, and providing evidence-based, patient-focused treatment. From diagnosis through long-term care, The Roxbury Institute reflects a commitment to enduring patient outcomes and comprehensive support.

To learn more, please visit: www.theroxburyinstitute.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dr-david-amron-testifies-before-us-senate-special-committee-on-aging-on-ai-enabled-fraud-targeting-older-americans-302840440.html

SOURCE The Roxbury Institute

Related Topics:
Continue Reading

Technology

Century Fasteners Corp. Exhibiting at the 2026 International Fastener Expo

Published

2 hours ago

on

September 21, 2026

By

Century Fasteners Corp. and Cherry Aerospace Relationship Showcased at the 2026 International Fastener Expo – October 7th-9th, 2026.

ELMHURST, N.Y., Sept. 21, 2026 //PRNewswire// — Century Fasteners Corp. (www.CenturyFasteners.com) is an authorized distributor for Cherry Aerospace (www.CherryAerospace.com).

Century Fasteners Corp. will exhibit at the 2026 International Fastener Expo (https://fastenershows.com/) in Phoenix, AZ, October 7th–9th, 2026, where Century will showcase its capabilities and relationship with Cherry Aerospace at Booth 2756.

In addition to making world-class Cherry products more broadly available to distributors and OEMs, the partnership expands Century’s existing services to the manufacturing community by enabling the company to provide deeper bill of material coverage to complement its product offering.

About Century Fasteners Corp.

Century Fasteners Corp. is a Master Distributor of fastener and consumable products to the military, aerospace, electronics, industrial, and commercial sectors. Founded in 1955, the AS and ISO certified company stocks more than 100,000 discrete parts, and offers a wide variety of value-added services, including VMI in-plant programs, custom kitting, and supply chain management solutions. Century Fasteners Corp. is an authorized stocking distributor for Cherry Aerospace (www.cherryaerospace.com). Service, Inventory, Integrity™

About Cherry Aerospace

Headquartered in Santa Ana, CA, Cherry Aerospace is a global leader in the design and manufacture of fastening systems for the aerospace industry. The Cherry® name is synonymous with aerospace fasteners, and the CherryMax® line of rivets is the most widely used in the industry. Cherry® Aerospace is well known for their industry leading blind rivets, blind bolts, rivetless nut plates, shear pin fasteners and installation tools. The company is a member of the SPS Fastener Division of Precision Castparts Corp.

For Cherry Aerospace and other product quotes for OEMs or Distributors, email the requirements to Century Fasteners Corp. at sales@centuryfasteners.com. To learn more about the products and services offered by Century Fasteners Corp., visit online at www.CenturyFasteners.com.

Media contact:

John Ringold – Director of Marketing
Century Fasteners Corp
800-221-0769
jringold@centuryfasteners.com
https://www.centuryfasteners.com/

Contact:
***@optonline.net

Photo(s):
https://www.prlog.org/13171987

Press release distributed by PRLog

View original content:https://www.prnewswire.com/news-releases/century-fasteners-corp-exhibiting-at-the-2026-international-fastener-expo-302885273.html

SOURCE Century Fasteners Corp.

Continue Reading

Technology

TMGM and Chelsea Football Club Extend Partnership into Fourth Year, Expanding into the Middle East

Published

2 hours ago

on

September 21, 2026

By

SYDNEY, Sept. 22, 2026 /PRNewswire/ — TMGM and Chelsea Football Club today announced the extension of their partnership into a fourth year, with the collaboration expanding beyond Asia-Pacific into the Middle East.

Since 2023, TMGM has served as Chelsea FC’s Official Online Forex and CFD Trading Partner in Asia-Pacific. The extension advances a partnership spanning matchday visibility, original content and fan engagement.

Three Years of Shared Momentum

In 2026, the partnership reached a milestone when TMGM branding appeared on the back of Chelsea men’s match shirts during the FA Cup – a first in the club’s history. TMGM also joined Chelsea FC’s 2026 Asia-Pacific Pre-Season Tour as an Official Partner, with open training, pitch-side access and post-match tunnel experiences. The tour included a visit by Chelsea players Cole Palmer and João Pedro to TMGM’s Sydney headquarters.

Earlier in 2026, TMGM presented The Famous CFC in Bangkok, where hundreds of supporters attended a live match screening and an exclusive appearance by former Chelsea captain John Terry.

These milestones formed part of a wider programme of premium home-match hospitality, behind-the-scenes visits at Cobham and player-led content under TMGM’s “Trade like a lion” campaign.

A Broader Platform for Year Four

In year four, TMGM’s expanded regional rights will support brand visibility at Chelsea home fixtures, original content featuring players and legends, regional digital campaigns and a China-focused performance series. The programme will also continue through The Famous CFC in selected markets and offer TMGM clients further hospitality and behind-the-scenes access across Chelsea’s matchday, stadium and training environments.

“Over three years, our relationship with Chelsea FC has evolved from regional activations to high-profile moments, including visibility on the club’s FA Cup shirts and its Asia-Pacific tour,” said TMGM. “Entering our fourth year and extending into the Middle East creates opportunities to connect with more audiences through experiences that reflect the ambition of both organisations.”

Chelsea Football Club said: “TMGM has focused on bringing its clients and our supporters closer to the club through digital-first content and in-person events across Asia-Pacific to great effect. We are pleased to extend the partnership into a fourth year and look forward to building on its momentum across the region and also the Middle East.”

About TMGM

Founded in 2013 in Sydney, Australia, TMGM Group is the Official Regional Partner of Chelsea Football Club. As a broker providing global financial product trading, TMGM is regulated by ASIC (Australia), VFSC (Vanuatu), FSC Mauritius, and FSA (Seychelles).

Disclaimer: Investing in leveraged products carries high risks and is not suitable for all investors. You have no interest in the underlying asset. Read the Client Agreement and other disclosure documents set forth on our website. The above information is provided by TMGM Group (Trademax Australia Limited, ABN 76 162 331 311, AFSL 436416, Trademax Global Markets (SE) Limited, FSA licence number SD224, Trademax Global Limited, VFSC 40356 & Trademax Global Markets (International) Pty Ltd, Company No. 195323, Mauritius Investment Dealer Licence No. GB22201012). 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/tmgm-and-chelsea-football-club-extend-partnership-into-fourth-year-expanding-into-the-middle-east-302884310.html

Continue Reading

Technology

Ridgeway Pharmacy Statement Regarding Website Security Incident Involving Third-Party Vendor

Published

2 hours ago

on

September 21, 2026

By

VICTOR, Mont., Sept. 21, 2026 /PRNewswire/ — Ridgeway Pharmacy, Ltd. (“Ridgeway”) is providing notice of an incident involving its pharmacy website, which was developed by a third-party vendor. Ridgeway identified operational issues on the website and promptly began an investigation with the assistance of external cybersecurity and forensic specialists. That investigation determined that a vulnerability in the vendor-supported website allowed an unknown third party to access the site using elevated privileges, and that certain information may have been accessible as a result. On August 21, 2026, Ridgeway determined that the information potentially involved may have included name, date of birth, address, prescription information, health information, insurance information, and, for a portion of the individuals, payment card information. Importantly, at no time did this incident involve Ridgeway’s internal systems.

Ridgeway takes the privacy and security of information seriously and holds the third parties that support its services to that same standard. Upon learning of this matter, Ridgeway secured and remediated the affected website, stood up a new platform, further restricted access, strengthened monitoring, implemented additional protections against unauthorized activity, and reported the incident to federal law enforcement.

Written notice has been mailed to individuals whose information may have been involved, and out of an abundance of caution Ridgeway is offering complimentary identity protection services through TransUnion, a leading identity protection provider. As a general precaution, individuals are encouraged to review their account statements, health plan explanations of benefits, and credit reports for any unfamiliar activity, to enroll in the complimentary services described in their notification letter, and to report any unusual activity to their financial institution.

Individuals with questions may call Ridgeway’s dedicated toll-free assistance line at 1-833-516-7133, available 8am – 8pm (ET).

View original content:https://www.prnewswire.com/news-releases/ridgeway-pharmacy-statement-regarding-website-security-incident-involving-third-party-vendor-302884264.html

SOURCE Ridgeway Pharmacy

Continue Reading

Trending